Table 2.
Baseline patient-reported symptoms by treatment-discontinuation status.
| Characteristic | Total (n=50) | Discontinued AI by 6 months due to MSK symptoms (n=7) | All Others (n=43) | p-value* | |||
|---|---|---|---|---|---|---|---|
| Mean | St Dev | Mean | St Dev | Mean | St Dev | ||
| Pain diary (0–10) | 1.7 | 1.3 | 1.9 | 1.2 | 1.6 | 1.3 | 0.52 |
| Depression (CESD) | 7.6 | 6.9 | 14.0 | 9.5 | 6.6 | 5.9 | 0.033 |
| Sleep (MOS-Sleep, SPDX2) | 31.2 | 18.8 | 47.1 | 17.9 | 28.6 | 17.8 | 0.013 |
| Fatigue (MFI) | |||||||
| General fatigue | 11.5 | 4.5 | 16.9 | 3.6 | 10.6 | 4.1 | 0.003 |
| Physical fatigue | 10.4 | 4.3 | 14.9 | 2.7 | 9.7 | 4.1 | 0.004 |
| Reduced activity | 9.3 | 4.4 | 12.9 | 3.9 | 8.7 | 4.3 | 0.021 |
| Reduced motivation | 7.6 | 4.0 | 11.2 | 2.3 | 7.0 | 4.0 | 0.006 |
| Mental fatigue | 8.3 | 4.3 | 9.0 | 3.7 | 8.1 | 4.4 | 0.49 |
| Cognitive function (MASQ) | |||||||
| Language | 14.0 | 3.4 | 15.0 | 4.9 | 14.4 | 3.8 | 0.86 |
| Visual-perception ability | 10.7 | 3.1 | 10.3 | 2.0 | 10.8 | 3.2 | 0.97 |
| Verbal memory | 16.3 | 3.6 | 17.3 | 1.6 | 16.1 | 3.8 | 0.42 |
| Visual-spatial memory | 14.0 | 3.3 | 14.7 | 2.1 | 13.9 | 3.4 | 0.31 |
| Attention/concentration | 15.5 | 3.4 | 16.8 | 2.9 | 15.4 | 3.5 | 0.31 |